Responsive Neurostimulation For Loss Of Control Eating

NAActive, not recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 10, 2019

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Loss of Control EatingObesity, Morbid
Interventions
DEVICE

responsive neurostimulation

The RNS® System is a novel, implantable therapeutic device that delivers responsive neurostimulation, an advanced technology designed to continuously monitor brain electrical activity, detect abnormal electrical activity and respond by delivering imperceptible levels of electrical stimulation to normalize that activity before an individual experiences seizures. This is an Early Feasibility Study determining the safety and efficacy of NAc-RNS in the treatment of LOC eating in treatment-refractory obesity.

Trial Locations (2)

19107

University of Pennsylvania, Philadelphia

94301

Stanford University, Stanford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NeuroPace

INDUSTRY

lead

University of Pennsylvania

OTHER